Publicacions científiques

Editorial Retraction

Retractions for: Yu HY, Cai YB, Liu Z. Activation of AMPK improves lipopolysaccharide-induced dysfunction of the blood-brain barrier in mice. Brain Inj. 2015;29(6):777-84. doi: 10.3109/02699052.2015.1004746

Any publicació:

2018

Número de revista:

Brain Injury vol. 32 n. 11

https://www.tandfonline.com/doi/full/10.1080/02699052.2018.1475604

Editorialist response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease

Autor/s:

Aziz TZ.

Disputes & Debates: Editors' Choice

Any publicació:

2018

Número de revista:

Neurology vol. 91 n. 5

http://n.neurology.org/content/91/5/240.1.extract

Comentari

Editors' note: A new potential biomarker for dementia with Lewy bodies: Skin nerve α-synuclein deposits

Autor/s:

Karam C, Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2018

Número de revista:

Neurology vol. 90 n. 11

http://n.neurology.org/content/90/11/530.1.extract

Comentari

Editors' note: A phase 3 trial of IV immunoglobulin for Alzheimer disease.

Autor/s:

Karam C, Griggs RC.

Disputes & Debates: Editors' Choice

Any publicació:

2018

Número de revista:

Neurology vol. 90 n. 3

http://n.neurology.org/content/90/3/144.1

Editors' note: A predictive model to identify Parkinson disease from administrative claims data

Autor/s:

Alcauskas M, Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2018

Número de revista:

Neurology vol. 91 n. 2

http://n.neurology.org/content/91/2/103.2.extract

Comentari

Editors' note: Activity limitations and subjective well-being after stroke

Autor/s:

Karam C, Griggs RC

Any publicació:

2018

Número de revista:

Neurology vol. 90 n. 7

http://n.neurology.org/content/90/7/341.1.extract

Editors' note: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.

Autor/s:

Alcauskas M, Galetta S.

Disputes & Debates: Editors' Choice

Any publicació:

2018

Número de revista:

Neurology vol. 91 n.12

http://n.neurology.org/content/91/12/580.1.extract

Editors' note: An interdisciplinary response to contemporary concerns about brain death determination.

Autor/s:

Karam C, Galetta S.

Disputes & Debates: Editors' Choice

Any publicació:

2018

Número de revista:

Neurology vol. 91 n.11

http://n.neurology.org/content/91/11/533.1.extract

Editors' note: Anti-cytosolic 5′-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases

Autor/s:

Karam C, Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2018

Número de revista:

Neurology vol. 90 n. 21

http://n.neurology.org/content/90/21/989.2.extract

Editors' note: Atrial fibrillation detected after stroke is related to a low risk of ischemic stroke recurrence

Autor/s:

Lewis A, Galetta S

Disputes & Debates: Editors' Choice

Any publicació:

2018

Número de revista:

Neurology vol. 91 n. 20

http://n.neurology.org/content/91/20/942.1.extract

Una iniciativa de:

Cercador

Editorial Retraction

Editorialist response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease

Editors' note: A new potential biomarker for dementia with Lewy bodies: Skin nerve α-synuclein deposits

Editors' note: A phase 3 trial of IV immunoglobulin for Alzheimer disease.

Editors' note: A predictive model to identify Parkinson disease from administrative claims data

Editors' note: Activity limitations and subjective well-being after stroke

Editors' note: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.

Editors' note: An interdisciplinary response to contemporary concerns about brain death determination.

Editors' note: Anti-cytosolic 5′-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases

Editors' note: Atrial fibrillation detected after stroke is related to a low risk of ischemic stroke recurrence

Trobes a faltar informació? Fes-nos arribar els teus suggeriments!